CWP
MIRM icon

Concord Wealth Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Concord Wealth Partners’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$585 Buy
+5
New +$502 ﹤0.01% 806
2026
Q1 		– Sell
-5
Closed -$395 – 565
2025
Q4 		$395 Hold
5
– – ﹤0.01% 783
2025
Q3 		$367 Hold
5
– – ﹤0.01% 779
2025
Q2 		$254 Buy
+5
New +$223 ﹤0.01% 802

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Concord Wealth Partners's MIRM Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 5 shares worth $585. The stake represents ﹤0.01% of the portfolio and ranks #806 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in MIRM as recently as Q4 2025.

Concord Wealth Partners first reported a position in MIRM in Q2 2025 and has held it in 4 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Concord Wealth Partners held 5 shares of Mirum Pharmaceuticals worth $585 as of Q2 2026.
  • Mirum Pharmaceuticals was a new Concord Wealth Partners position in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #806 holding.
  • Concord Wealth Partners first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.